NCT07419087 Trunk Impairment Scale - Adaptation and Validation in French
| NCT ID | NCT07419087 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Centre Mutualiste de Rééducation et de Réadaptation Fonctionnelles de Kerpape |
| Condition | Stroke (CVA) or Transient Ischemic Attack |
| Study Type | INTERVENTIONAL |
| Enrollment | 67 participants |
| Start Date | 2026-03-19 |
| Primary Completion | 2026-03-25 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 67 participants in total. It began in 2026-03-19 with a primary completion date of 2026-03-25.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The objective of this project is to verify the validity and determine the clinimetric properties after translation and adaptation into French of the Trunk Impairment Scale (TIS), a scale for measuring trunk control and seated balance.
Eligibility Criteria
Inclusion criteria (Phase 1): * Patients over 18 years of age * Patients who have had a stroke * Full understanding of the French language * No cognitive disorders * No prior exposure to the TIS scale * Covered by a social security system * Having been informed, having agreed to participate in the study, and having signed the free and informed consent form. Inclusion criteria (Phase 2): * Patients aged over 18 and under 85 years * Having had a stroke, with no time-since-onset limitation * Able to sit for 10 seconds without hand support * Able to provide informed consent * With an NIHSS score between 2 and 26 * Covered by a social security system * Having been informed, having agreed to participate in the study, and having signed the free and informed consent form Exclusion Criteria (Phase 1): * Insufficient command of the French language * Inability to understand instructions * Persons deprived of liberty (by judicial or administrative decision) * Adults under legal protection or unable to express their consent * Pregnant or breastfeeding women Exclusion Criteria (Phase 2): * Contraindication to the sitting position or to hip adduction (hip prosthesis) * History of orthopedic or neurological disorders affecting sitting balance * Insufficient command of the French language * Inability to understand instructions * Person deprived of liberty (by judicial or administrative decision) * Adult under legal protection or unable to express consent * Pregnant or breastfeeding woman
Contact & Investigator
Plouzennec Jean-Philippe, Physiotherapist
PRINCIPAL INVESTIGATOR
Centre de Kerpape
Frequently Asked Questions
Who can join the NCT07419087 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 85 Years, studying Stroke (CVA) or Transient Ischemic Attack. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07419087 currently recruiting?
Yes, NCT07419087 is actively recruiting participants. Contact the research team at jean-philippe.plouzennec@vyv3.fr for enrollment information.
Where is the NCT07419087 trial being conducted?
This trial is being conducted at Ploemeur, France.
Who is sponsoring the NCT07419087 clinical trial?
NCT07419087 is sponsored by Centre Mutualiste de Rééducation et de Réadaptation Fonctionnelles de Kerpape. The principal investigator is Plouzennec Jean-Philippe, Physiotherapist at Centre de Kerpape. The trial plans to enroll 67 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.